Legend Biotech
first in human phase dose finding study in legend | Legend Biotech
Company
Deck Type
IPO
Sector
Industry
Deck date
May 2020
Slide
13 of 42
Related slides by other companies
Larimar Therapeutics
Investor Presentation
October 2022
upcoming phase four week dose exploration study | Larimar Therapeutics
Oculis
Investor Presentation
April 2023
phase study post positive meeting set stages | Oculis
DICE Therapeutics
Investor Presentation
March 2023
phase studies expected to determine optimal dosing regimen and maximal therapeutic effect dice | DICE Therapeutics
BioNTech
Results
November 2020
highlights covid | BioNTech
Other recent decks by Legend Biotech
See all presentations (4 decks)
Investor Presentation
January 2024
Results
November 2023
Results
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io